You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oxaliplatin

Showing 51 - 75 of 2,879
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Beijing Cancer Hospital
Aug 7, 2023

MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • +3 more
  • (no location specified)
Apr 23, 2023

Neuroblastoma Trial in United States (Tolcapone, Oxaliplatin)

Terminated
  • Neuroblastoma
  • Little Rock, Arkansas
  • +8 more
Aug 23, 2022

Oxaliplatin - Induced Peripheral Neuropathy in Gastrointestinal

Enrolling by invitation
  • Gastrointestinal Tract Cancer
  • Peripheral Neuropathy
  • polymorphism analysis
  • Cairo, Abbasia, Egypt
    Ain Shams University hospitals
Jul 19, 2022

Gastric Cancer Trial in Gyeonggi-do (Oxaliplatin, Capecitabine)

Recruiting
  • Gastric Cancer
  • Gyeonggi-do, Korea, Republic of
    Hallym University Medical Center
Feb 4, 2022

Neurotoxicity in Gastrointestinal Cancer Patients Receiving

Recruiting
  • Gastrointestinal Cancer
  • Folfox Protocol
  • Cairo, Abassia, Egypt
    Ain shams university
Aug 8, 2022

Liver, Cancer of, Primary Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Liver, Cancer of, Primary Resectable
  • Oxaliplatin
  • +5 more
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Jan 18, 2023

Gastric Cancer, Gastric Adenocarcinoma, Effects of Chemo Trial in Taiwan (leucovorin, oxaliplatin, docetaxel, S-1)

Recruiting
  • Gastric Cancer
  • +3 more
  • leucovorin, oxaliplatin, docetaxel, S-1
  • Kaohsiung, Taiwan
  • +3 more
May 24, 2022

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)

Active, not recruiting
  • Gastric Cancer
  • Mykolaiv, Ukraine
    Ukrainian Society of Clinical Oncology
Apr 11, 2022

Gastric Cancer Trial in Seoul (Docetaxel (XRP6976), Oxaliplatin (SR96669), S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil +

Active, not recruiting
Has Results
  • Gastric Cancer
  • Docetaxel (XRP6976)
  • +2 more
  • Seoul, Korea, Republic of
    Administrative Office
May 3, 2022

Digestive Cancer Trial in Pierre-Bénite, Saint-Herblain, Saint-Mandé (5-Fluorouracil, L-Folinic acid, Oxaliplatin)

Terminated
  • Digestive Cancer
  • Pierre-Bénite, France
  • +2 more
Apr 19, 2022

Colon Cancer, Rectal Cancer Trial in United States (TAS-102, oxaliplatin, irinotecan with bevacizumab)

Not yet recruiting
  • Colon Cancer
  • Rectal Cancer
  • TAS-102, oxaliplatin, irinotecan with bevacizumab
  • Elizabeth, New Jersey
  • +6 more
Apr 7, 2023

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811;SHR-1701;capecitabine;oxaliplatin)

Not yet recruiting
  • HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jan 3, 2023

Combined Hepatocellular Cholangiocarcinoma Trial (gemcitabine ,oxaliplatin,anlotinib,Sintilimab)

Not yet recruiting
  • Combined Hepatocellular Cholangiocarcinoma
  • gemcitabine ,oxaliplatin,anlotinib,Sintilimab
  • (no location specified)
Sep 10, 2023

Rectal Cancer Trial in Mannheim (mFOLFOX (neoadjuvant), XELOX (neoadjuvant), mFOLFOX (adjuvant))

Recruiting
  • Rectal Cancer
  • mFOLFOX (neoadjuvant)
  • +6 more
  • Mannheim, Germany
    Unversity Hospital Mannheim
Aug 12, 2022

Colorectal Cancer Stage IV Trial in Sao Paulo (mFOLFIRINOX)

Recruiting
  • Colorectal Cancer Stage IV
  • Sao Paulo, SP, Brazil
    ICESP
Apr 28, 2022

Gastric Cancer Trial in Jinan (SHR1210, Apatinib, S1)

Recruiting
  • Gastric Cancer
  • Jinan, Shandong, China
    Qilu hospital of Shandong univertisy
Mar 30, 2022

HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Locally Advanced Resectable Gastric Cancer
  • (no location specified)
Sep 3, 2023

Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick

Recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Oxaliplatin
  • Trifluridine and Tipiracil Hydrochloride
  • Elizabeth, New Jersey
  • +5 more
Oct 17, 2022

Biliary Tract Tumor Trial in Nanjing (Tislelizumab, Lenvatinib, Oxaliplatin)

Recruiting
  • Biliary Tract Tumor
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Mar 14, 2022

Phase II, Open-label, Parallel 2-arm, Multi-center Trial in Kaohsiung, Taichung, Tainan (Gemcitabine 1000 mg, Nab paclitaxel,

Recruiting
  • Phase II, Open-label, Parallel 2-arm, Multi-center
  • Gemcitabine 1000 mg
  • +4 more
  • Kaohsiung, Taiwan
  • +2 more
Jun 12, 2022

Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)

Terminated
Has Results
  • Colorectal Neoplasms
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Dec 30, 2021

Metastatic Colorectal Cancer Trial (Niraparib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Jun 7, 2022